EXAS NASDAQ
Exact Sciences Corporation
1W: +1.0%
1M: +1.4%
3M: +3.5%
YTD: +3.1%
1Y: +136.9%
3Y: +58.6%
5Y: -19.7%
$104.91
Last traded 2026-03-23 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
11 relationships8
As Filer
counterparties named
3
As Counterparty
mentioned by others
3
Rel. Types
2021-11-29
Earliest Filing
2026-03-23
Latest Filing
partner: 4
acquirer: 3
target: 1
Counterparties (Filed by EXAS)
8 relationshipsCompanies named in EXAS's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Abbott Laboratories | ABT | acquirer | Acquired Exact Sciences Corporation in a merger transaction completed on March 23, 2026. | 2026-03-23 | View |
| Badger Merger Sub I, Inc. | — | target | Wholly owned subsidiary of Abbott Laboratories that merged with Exact Sciences Corporation. | 2026-03-23 | View |
| Abbott Laboratories | ABT | acquirer | Acquired Exact Sciences Corporation in a merger transaction. | 2025-11-20 | View |
| Badger Merger Sub I, Inc. | — | acquirer | Wholly owned subsidiary of Abbott Laboratories used as the merger vehicle. | 2025-11-20 | View |
| Exact Sciences Laboratories, LLC | EXAS | partner | Collateral provider and initial servicer for the securitization facility. | 2022-06-30 | View |
| Genomic Health, Inc. | — | partner | Collateral provider for the securitization facility. | 2022-06-30 | View |
| PNC Capital Markets, LLC | — | partner | Structuring agent for the securitization facility. | 2022-06-30 | View |
| Pfizer Inc. | PFE | partner | Amendment to promotion agreement ending Pfizer's promotion of Cologuard and establishing payment terms. | 2021-11-29 | View |
Mentioned As Counterparty
3 mentionsOther companies that named EXAS in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| ABT ABBOTT LABORATORIES | acquirer | Target of the proposed acquisition by Abbott Laboratories | 2026-03-09 | View |
| ABT ABBOTT LABORATORIES | acquirer | Target of the acquisition funded by the notes offering | 2026-02-26 | View |
| ABT ABBOTT LABORATORIES | acquirer | Target company in the merger agreement with Abbott Laboratories. | 2025-11-20 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-03-23 | Material Agreement; Termination of Agreement; Acquisition/Disposition; Delisting Notice; Change in C | Agreement Acquisition | View |
| 2026-02-20 | Submission of Matters to a Vote of Security Holders | View | |
| 2026-02-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-02-10 | Other Events | View | |
| 2025-12-29 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-11-20 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2025-11-03 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-06 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-06-16 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-05-01 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-29 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-02-19 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-13 | Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Creation of | Agreement | View |
| 2025-01-06 | Departure/Election of Directors; Appointment of Officers | View | |
| 2024-11-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-06-17 | Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View | |
| 2024-06-03 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure | View | |
| 2024-04-25 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2024-04-17 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2024-02-21 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR